Your shopping cart is currently empty

3-Methyltoxoflavin (3-methyl toxoflavin) is an effective inhibitor of protein disulfide isomerase (PDI) and its IC50 value is 170 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $46 | In Stock | In Stock | |
| 5 mg | $108 | In Stock | In Stock | |
| 10 mg | $163 | In Stock | In Stock | |
| 25 mg | $293 | In Stock | In Stock | |
| 50 mg | $425 | In Stock | In Stock | |
| 100 mg | $619 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $119 | In Stock | In Stock |
| Description | 3-Methyltoxoflavin (3-methyl toxoflavin) is an effective inhibitor of protein disulfide isomerase (PDI) and its IC50 value is 170 nM. |
| Targets&IC50 | PDI:170 nM |
| In vitro | 3-Methyltoxoflavin is an effective inhibitor of Protein disulfide isomerase (PDI), exhibiting significant potency with an IC50 value of 170 nM, and demonstrating marked toxicity across various human glioblastoma cell lines. It stands out as the most potent PDI inhibitor identified in screening efforts. Research involving Bromouridine labeling and sequencing (Bru-seq) has shown that 3-Methyltoxoflavin activates the Nrf2 antioxidant response, triggers ER stress response, and promotes autophagy. It achieves this by increasing the transcription and protein levels of heme oxygenase 1 and SLC7A11, while simultaneously downregulating expression of PDI target genes, such as TXNIP and EGR1. Notably, the cell death induced by 3-Methyltoxoflavin does not occur through traditional pathways like apoptosis or necrosis, but rather through a combination of autophagy and ferroptosis. |
| Synonyms | 3-methyl toxoflavin |
| Molecular Weight | 207.19 |
| Formula | C8H9N5O2 |
| Cas No. | 32502-62-8 |
| Smiles | Cc1nn(C)c2nc(=O)n(C)c(=O)c2n1 |
| Relative Density. | 1.56 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 150 mg/mL (723.97 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (24.13 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.